Form Approved
OMB No. 0920-0666
Exp. Date: xx/xx/20xx
www.cdc.gov/nhsn
Hemovigilance Module
Adverse Reaction
Hypotensive Transfusion Reaction
*Required for saving
*Facility ID#: _________ |
NHSN Adverse Reaction #: __________ |
|
|||||||||||||||||||
Patient Information |
|||||||||||||||||||||
*Patient ID: ___________________ |
*Gender: |
M |
F |
Other |
*Date of Birth: ____/____/_____ |
||||||||||||||||
Social Security #: ______________ |
Secondary ID: _________________ |
Medicare #: _________________ |
|||||||||||||||||||
Last Name: ___________________ |
First Name: ____________________ |
Middle Name: _______________ |
|||||||||||||||||||
Ethnicity |
Hispanic or Latino |
Not Hispanic or Not Latino |
|||||||||||||||||||
|
|||||||||||||||||||||
Race |
American Indian/Alaska Native |
Asian |
Black or African American |
||||||||||||||||||
|
Native Hawaiian/Other Pacific Islander |
White |
|||||||||||||||||||
*Blood Group: |
A- |
A+ |
B- |
B+ |
AB- |
AB+ |
O- |
O+ |
Blood type not done |
Patient Medical History (Use worksheet on page 4 for additional codes and descriptions.) |
||||
|
(part 1) List the patient’s admitting diagnosis. (Use ICD-10 Diagnostic codes/descriptions) |
|||
|
Code: ______________ |
Description: __________________________________________________ |
||
|
Code: ______________ |
Description: __________________________________________________ |
||
|
Code: ______________ |
Description: __________________________________________________ |
||
|
(part 2) List the patient’s underlying indication for transfusion. (Use ICD-10 Diagnostic codes/descriptions) |
|||
|
Code: ______________ |
Description: __________________________________________________ |
||
|
Code: ______________ |
Description: __________________________________________________ |
||
|
Code: ______________ |
Description: _________________________________________________ |
||
|
(part 3) List the patient’s comorbid conditions at the time of the transfusion related to the adverse reaction. (Use ICD-10 Diagnostic codes/descriptions) |
UNKNOWN |
||
NONE |
||||
|
Code: ______________ |
Description: __________________________________________________ |
||
|
Code: ______________ |
Description: __________________________________________________ |
||
|
Code: ______________ |
Description: __________________________________________________ |
||
Continued >> |
||||
Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).
Public reporting burden of this collection of information is estimated to average 20 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333 ATTN: PRA (0920-0666). CDC 57.312 (Front) Rev 1, v8.8 |
Hypotensive Transfusion Reaction
Patient Medical History (Use worksheet on page 4 for additional codes and descriptions.) |
|||||||||||||||||||||||||||||||||||||
|
(part 4) List the patient’s relevant medical procedure including past procedures and procedures to be performed during the current hospital or outpatient stay. (Use ICD-10 Procedure codes/descriptions) |
UNKNOWN |
|||||||||||||||||||||||||||||||||||
NONE |
|||||||||||||||||||||||||||||||||||||
|
Code: _______________ |
Description: _____________________________________________ |
|||||||||||||||||||||||||||||||||||
|
Code: _______________ |
Description: ________________________________________________ |
|||||||||||||||||||||||||||||||||||
|
Code: _______________ |
Description: ____________________________________________ |
|||||||||||||||||||||||||||||||||||
|
(part 5) Additional Information ________________________________________________________________________ |
||||||||||||||||||||||||||||||||||||
|
_____________________________________________________________________________________________________ |
||||||||||||||||||||||||||||||||||||
|
_____________________________________________________________________________________________________ |
||||||||||||||||||||||||||||||||||||
Transfusion History (Use worksheet on page 4 for additional transfusion history.) |
|||||||||||||||||||||||||||||||||||||
|
Has the patient received a previous transfusion? |
YES |
NO |
UNKNOWN |
|||||||||||||||||||||||||||||||||
|
**If yes, provide information about the transfusion event. If not, skip to Reaction Details section. |
||||||||||||||||||||||||||||||||||||
|
Blood Product: |
WB |
RBC |
Platelet |
Plasma |
Cryoprecipitate |
Granulocyte |
||||||||||||||||||||||||||||||
|
Date of Transfusion: |
____/____/_____ |
UNKNOWN |
||||||||||||||||||||||||||||||||||
|
Did the patient experience a transfusion adverse reaction? |
YES |
NO |
||||||||||||||||||||||||||||||||||
|
If yes, provide information about the transfusion adverse reaction. |
||||||||||||||||||||||||||||||||||||
|
Type of transfusion adverse reaction: |
Allergic |
AHTR |
DHTR |
DSTR |
FNHTR |
|||||||||||||||||||||||||||||||
|
HTR |
TTI |
PTP |
TACO |
TAD |
TA-GVHD |
TRALI |
UNKNOWN |
|||||||||||||||||||||||||||||
|
OTHER |
Specify __________________________________________________________________________ |
|||||||||||||||||||||||||||||||||||
Reaction Details |
|||||||||||||||||||||||||||||||||||||
*Date reaction occurred: ____/____/____ |
*Time reaction occurred: __ __:__ __ |
Time unknown |
|||||||||||||||||||||||||||||||||||
*Facility location where patient was transfused: |
______________________________________________ |
||||||||||||||||||||||||||||||||||||
*Is this reaction associated with an incident? |
Yes |
No |
If Yes, Incident #: ________________ |
||||||||||||||||||||||||||||||||||
After recognition of the transfusion reaction, was the current transfusion: |
|||||||||||||||||||||||||||||||||||||
|
Continued |
Stopped and restarted |
Stopped indefinitely |
||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
Investigation Results |
|||||||||||||||||||||||||||||||||||||
* Hypotensive transfusion reaction |
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
*Case Definition |
||||||||||||||||||||||||||||||||||||
|
Check all that occurred during or within 1 hour of cessation of transfusion: |
||||||||||||||||||||||||||||||||||||
|
All other adverse reactions presenting with hypotension are excluded. |
||||||||||||||||||||||||||||||||||||
|
Hypotension |
||||||||||||||||||||||||||||||||||||
|
Check all that apply: |
||||||||||||||||||||||||||||||||||||
|
Hypotension occurs, does not meet the criteria above. Other, more specific reaction definitions do not apply. |
||||||||||||||||||||||||||||||||||||
|
None of the above |
||||||||||||||||||||||||||||||||||||
Continued >> |
Hypotensive Transfusion Reaction
Investigation Results (continued) |
||||||||||||||||
Other signs and symptoms: (check all that apply) |
||||||||||||||||
Generalized: |
Chills/rigors |
Fever |
Nausea/vomiting |
|||||||||||||
Cardiovascular: |
Shock |
|||||||||||||||
Cutaneous: |
Edema |
Flushing |
Jaundice |
|||||||||||||
Other rash |
Pruritus (itching) |
Urticaria (hives) |
||||||||||||||
Hemolysis/Hemorrhage: |
Disseminated intravascular coagulation |
Hemoglobinemia |
||||||||||||||
Positive antibody screen |
||||||||||||||||
Pain: |
Abdominal pain |
Back pain |
Flank pain |
Infusion site pain |
||||||||||||
Renal: |
Hematuria |
Hemoglobinuria |
Oliguria |
|||||||||||||
Respiratory: |
Bilateral infiltrates on chest x-ray |
Bronchospasm |
Cough |
|||||||||||||
Hypoxemia |
Shortness of breath |
|||||||||||||||
Other: (specify) __________________________________________________________________________ |
||||||||||||||||
|
||||||||||||||||
|
*Severity |
|||||||||||||||
|
Did the patient receive or experience any of the following? (Response definitions listed in protocol) |
|||||||||||||||
|
Symptomatic treatment only |
Hospitalization, inlcuding prolonged hospitalization |
||||||||||||||
|
Life-threatening reaction |
Disability and/or incapacitation |
||||||||||||||
|
Congenital anomaly or birth defect(s) of the fetus |
Death |
||||||||||||||
|
Other medically important conditions |
Unknown or not stated |
||||||||||||||
|
||||||||||||||||
|
*Imputability |
|||||||||||||||
|
Which best describes the relationship between the transfusion and the reaction? |
|||||||||||||||
|
The patient has no other conditions that could explain hypotension. |
|||||||||||||||
|
There are other potential causes present that could explain hypotension, but transfusion is the most likely cause. |
|||||||||||||||
|
Other conditions that could readily explain hypotension are present. |
|||||||||||||||
|
Evidence is clearly in favor of a cause other than the transfusion, but transfusion cannot be excluded. |
|||||||||||||||
|
There is conclusive evidence beyond reasonable doubt of a cause other than the transfusion. |
|||||||||||||||
|
The relationship between the adverse reaction and the transfusion is unknown or not stated. |
|||||||||||||||
|
|
|||||||||||||||
|
How did the patient respond the cessation of transfusion and supportive treatment? |
|||||||||||||||
|
Responds rapidly (i.e., within 10 minutes) to cessation of transfusion and supportive treatment. |
|||||||||||||||
|
The patient does not respond rapidly to cessation of transfusion and supportive treatment. |
|||||||||||||||
|
||||||||||||||||
|
Did the transfusion occur at your facility? |
YES |
NO |
|||||||||||||
|
||||||||||||||||
|
When did the reaction occur in relation to the transfusion? |
|||||||||||||||
|
Occurs less than 15 minutes after the start of the transfusion. |
|||||||||||||||
|
Onset is between 15 minutes after start and 1 hour after cessation of transfusion. |
|||||||||||||||
|
|
|
|
|||||||||||||
Continued >> |
Hypotensive Transfusion Reaction
Investigation Results (continued) |
||
Designations for case definition, severity, and imputability will be automatically assigned in the NHSN application based on responses in the corresponding investigation results section above. |
||
Do you agree with the case definition designation? |
YES |
NO |
Please indicate your designation _________________________________________________________ |
||
Do you agree with the severity designation? |
YES |
NO |
Please indicate your designation _________________________________________________________ |
||
Do you agree with the imputability designation? |
YES |
NO |
Please indicate your designation _________________________________________________________ |
||
Additional Information _____________________________________________________________________ |
||
________________________________________________________________________________________ |
||
________________________________________________________________________________________ |
Patient Treatment |
||||||||||||||||||||
|
*Did the patient receive treatment for the transfusion reaction? |
YES |
NO |
UNKNOWN |
||||||||||||||||
|
If yes, select treatment(s): |
|||||||||||||||||||
|
Medication (Select the type of medication) |
|||||||||||||||||||
|
Antipyretics |
Antihistamines |
Inotropes/Vasopressors |
Bronchodilator |
Diuretics |
|||||||||||||||
|
Intravenous Immunoglobulin |
Intravenous steroids |
Corticosteroids |
Antibiotics |
||||||||||||||||
|
Antithymocyte globulin |
Cyclosporin |
H1 receptor blockers |
Other |
||||||||||||||||
|
||||||||||||||||||||
|
Volume resuscitation (Intravenous colloids or crystalloids) |
|||||||||||||||||||
|
||||||||||||||||||||
|
Respiratory support (Select the type of support) |
|||||||||||||||||||
|
Mechanical ventilation |
Noninvasive ventilation |
Oxygen |
|||||||||||||||||
|
||||||||||||||||||||
|
Renal replacement therapy (Select the type of therapy) |
|||||||||||||||||||
|
Hemodialysis |
Peritoneal |
Continuous Veno-Venous Hemofiltration |
|||||||||||||||||
|
||||||||||||||||||||
|
Phlebotomy |
|||||||||||||||||||
|
Other |
Specify: ____________________________________________________________ |
||||||||||||||||||
|
Outcome |
||||||||||||||||||
|
*Outcome: |
Death |
Major or long-term sequelae |
Minor or no sequelae |
Not determined |
|||||||||||||
|
Date of Death: |
____/____/_____ |
|
|||||||||||||||
|
^*If recipient died, relationship of transfusion to death: |
|||||||||||||||||
|
Definite |
Probable |
Possible |
Doubtful |
Ruled Out |
Not determined |
||||||||||||
|
Cause of death: |
______________________________________________________ |
||||||||||||||||
|
Was an autopsy performed? |
Yes |
No |
|||||||||||||||
|
||||||||||||||||||
Continued >> |
Hypotensive Transfusion Reaction
Component Details (Use worksheet on page 4 for additional units.) |
|||||||||||
*Was a particular unit implicated in (i.e., responsible for) the adverse reaction? |
Yes |
No |
N/A |
||||||||
Transfusion Start and End Date/Time |
*Component code (check system used) |
Amount transfused at reaction onset |
Unit number |
*Unit expiration Date/Time |
*Blood group of unit |
Implicated Unit? |
|||||
^IMPLICATED UNIT |
|||||||||||
____/____/___ |
ISBT-128 |
Entire unit Partial unit ______mL |
__ __ __ __ __ |
___/___/_____ |
A- |
A+ |
B- |
Y |
|||
___ ___:_____ |
Codabar |
__ __ |
|||||||||
____/____/___ |
___ ___ ___ ___ ___ |
__ __ __ __ __ __ |
_____ : _____ |
B+ |
AB- |
AB+ |
|||||
___ ___:_____ |
_________________ |
__ __ __ |
O- |
O+ |
N/A |
||||||
____/____/___ |
ISBT-128 |
Entire unit Partial unit ______mL |
__ __ __ __ __ |
___/___/_____ |
A- |
A+ |
B- |
N |
|||
___ ___:___ _ |
Codabar |
__ __ |
|||||||||
____/____/___ |
___ ___ ___ ___ ___ |
__ __ __ __ __ __ |
_____ : _____ |
B+ |
AB- |
AB+ |
|||||
___ ___:_____ |
_________________ |
__ __ __ |
O- |
O+ |
N/A |
||||||
____/____/___ |
ISBT-128 |
Entire unit Partial unit ______mL |
__ __ __ __ __ |
___/___/_____ |
A- |
A+ |
B- |
N |
|||
___ ___:_____ |
Codabar |
__ __ |
|||||||||
____/____/___ |
___ ___ ___ ___ ___ |
__ __ __ __ __ __ |
_____ : _____ |
B+ |
AB- |
AB+ |
|||||
___ ___:___ __ |
_________________ |
__ __ __ |
O- |
O+ |
N/A |
Custom Fields |
|||
Label |
|
Label |
|
_______________ |
______/______/________ |
________________ |
______/______/________ |
_______________ |
___________________ |
________________ |
__________________ |
_______________ |
___________________ |
________________ |
__________________ |
_______________ |
___________________ |
________________ |
__________________ |
Comments |
|||
______________________________________________________________________________________ |
|||
______________________________________________________________________________________ |
|||
______________________________________________________________________________________ |
|||
______________________________________________________________________________________ |
|||
|
Hemovigilance Module
Additional Worksheet
Patient Medical History |
|||||
|
(part 1) List the patient’s admitting diagnosis. (Use ICD-10 Diagnostic codes/descriptions) |
||||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
|
|
|||
|
(part 2) List the patient’s underlying indication for transfusion. (Use ICD-10 Diagnostic codes/descriptions) |
||||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: _________________________________________________ |
|||
|
(part 3) List the patient’s comorbid conditions at the time of the transfusion related to the adverse reaction. (Use ICD-10 Diagnostic codes/descriptions) |
UNKNOWN |
|||
NONE |
|||||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
(part 4) List the patient’s relevant medical procedure including past procedures and procedures to be performed during the current hospital or outpatient stay. (Use ICD-10 Procedure codes/descriptions) |
UNKNOWN |
|||
NONE |
|||||
|
Code: _______________ |
Description: _____________________________________________ |
|||
|
Code: _______________ |
Description: ________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: ______________ |
Description: __________________________________________________ |
|||
|
Code: _______________ |
Description: ____________________________________________ |
|||
|
(part 5) Additional Information ________________________________________________________________________ |
||||
|
_____________________________________________________________________________________________________ |
||||
|
_____________________________________________________________________________________________________ |
||||
|
_____________________________________________________________________________________________________ |
Hemovigilance Module
Additional Worksheet
Transfusion History |
|||||||||||||||||||||||||||
|
Has the patient received a previous transfusion? |
YES |
NO |
||||||||||||||||||||||||
|
**If yes, provide information about the transfusion event. If not, skip to Reaction Details section. |
||||||||||||||||||||||||||
|
Blood Product: |
WB |
RBC |
Platelet |
Plasma |
Cryoprecipitate |
Granulocyte |
||||||||||||||||||||
|
Date of Transfusion: |
____/____/_____ |
UNKNOWN |
||||||||||||||||||||||||
|
Did the patient experience a transfusion adverse reaction? |
YES |
NO |
||||||||||||||||||||||||
|
If yes, provide information about the transfusion adverse reaction. |
||||||||||||||||||||||||||
|
Type of transfusion adverse reaction: |
Allergic |
AHTR |
DHTR |
DSTR |
FNHTR |
|||||||||||||||||||||
|
HTR |
TTI |
PTP |
TACO |
TAD |
TA-GVHD |
TRALI |
UNKNOWN |
|||||||||||||||||||
|
OTHER |
Specify __________________________________________________________________________ |
|||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||
|
Has the patient received a previous transfusion? |
YES |
NO |
||||||||||||||||||||||||
|
**If yes, provide information about the transfusion event. If not, skip to Reaction Details section. |
||||||||||||||||||||||||||
|
Blood Product: |
WB |
RBC |
Platelet |
Plasma |
Cryoprecipitate |
Granulocyte |
||||||||||||||||||||
|
Date of Transfusion: |
____/____/_____ |
UNKNOWN |
||||||||||||||||||||||||
|
Did the patient experience a transfusion adverse reaction? |
YES |
NO |
||||||||||||||||||||||||
|
If yes, provide information about the transfusion adverse reaction. |
||||||||||||||||||||||||||
|
Type of transfusion adverse reaction: |
Allergic |
AHTR |
DHTR |
DSTR |
FNHTR |
|||||||||||||||||||||
|
HTR |
TTI |
PTP |
TACO |
TAD |
TA-GVHD |
TRALI |
UNKNOWN |
|||||||||||||||||||
|
OTHER |
Specify __________________________________________________________________________ |
|||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||
|
Has the patient received a previous transfusion? |
YES |
NO |
||||||||||||||||||||||||
|
**If yes, provide information about the transfusion event. If not, skip to Reaction Details section. |
||||||||||||||||||||||||||
|
Blood Product: |
WB |
RBC |
Platelet |
Plasma |
Cryoprecipitate |
Granulocyte |
||||||||||||||||||||
|
Date of Transfusion: |
____/____/_____ |
UNKNOWN |
||||||||||||||||||||||||
|
Did the patient experience a transfusion adverse reaction? |
YES |
NO |
||||||||||||||||||||||||
|
If yes, provide information about the transfusion adverse reaction. |
||||||||||||||||||||||||||
|
Type of transfusion adverse reaction: |
Allergic |
AHTR |
DHTR |
DSTR |
FNHTR |
|||||||||||||||||||||
|
HTR |
TTI |
PTP |
TACO |
TAD |
TA-GVHD |
TRALI |
UNKNOWN |
|||||||||||||||||||
|
OTHER |
Specify __________________________________________________________________________ |
|||||||||||||||||||||||||
|
|
|
Hemovigilance Module
Additional Worksheet
Component Details |
|||||||||||
*Was a particular unit implicated in (i.e., responsible for) the adverse reaction? |
Yes |
No |
N/A |
||||||||
Transfusion Start and End Date/Time |
*Component code (check system used) |
Amount transfused at reaction onset |
Unit number |
*Unit expiration Date/Time |
*Blood group of unit |
Implicated Unit? |
|||||
____/____/_____ |
ISBT-128 |
Entire unit Partial unit ______mL |
__ __ __ __ __ |
___/___/_____ |
A- |
A+ |
B- |
N |
|||
___ ___:___ ___ |
Codabar |
__ __ |
|||||||||
____/____/_____ |
___ ___ ___ ___ ___ |
__ __ __ __ __ __ |
_____ : _____ |
B+ |
AB- |
AB+ |
|||||
___ ___:___ ___ |
_________________ |
__ __ __ |
O- |
O+ |
N/A |
||||||
____/____/_____ |
ISBT-128 |
Entire unit Partial unit ______mL |
__ __ __ __ __ |
___/___/_____ |
A- |
A+ |
B- |
N |
|||
___ ___:___ ___ |
Codabar |
__ __ |
|||||||||
____/____/_____ |
___ ___ ___ ___ ___ |
__ __ __ __ __ __ |
_____ : _____ |
B+ |
AB- |
AB+ |
|||||
___ ___:___ ___ |
_________________ |
__ __ __ |
O- |
O+ |
N/A |
||||||
____/____/_____ |
ISBT-128 |
Entire unit Partial unit ______mL |
__ __ __ __ __ |
___/___/_____ |
A- |
A+ |
B- |
N |
|||
___ ___:___ ___ |
Codabar |
__ __ |
|||||||||
____/____/_____ |
___ ___ ___ ___ ___ |
__ __ __ __ __ __ |
_____ : _____ |
B+ |
AB- |
AB+ |
|||||
___ ___:___ ___ |
_________________ |
__ __ __ |
O- |
O+ |
N/A |
||||||
____/____/_____ |
ISBT-128 |
Entire unit Partial unit ______mL |
__ __ __ __ __ |
___/___/_____ |
A- |
A+ |
B- |
N |
|||
___ ___:___ ___ |
Codabar |
__ __ |
|||||||||
____/____/_____ |
___ ___ ___ ___ ___ |
__ __ __ __ __ __ |
_____ : _____ |
B+ |
AB- |
AB+ |
|||||
___ ___:___ ___ |
_________________ |
__ __ __ |
O- |
O+ |
N/A |
||||||
____/____/_____ |
ISBT-128 |
Entire unit Partial unit ______mL |
__ __ __ __ __ |
___/___/_____ |
A- |
A+ |
B- |
N |
|||
___ ___:___ ___ |
Codabar |
__ __ |
|||||||||
____/____/_____ |
___ ___ ___ ___ ___ |
__ __ __ __ __ __ |
_____ : _____ |
B+ |
AB- |
AB+ |
|||||
___ ___:___ ___ |
_________________ |
__ __ __ |
O- |
O+ |
N/A |
||||||
____/____/_____ |
ISBT-128 |
Entire unit Partial unit ______mL |
__ __ __ __ __ |
___/___/_____ |
A- |
A+ |
B- |
N |
|||
___ ___:___ ___ |
Codabar |
__ __ |
|||||||||
____/____/_____ |
___ ___ ___ ___ ___ |
__ __ __ __ __ __ |
_____ : _____ |
B+ |
AB- |
AB+ |
|||||
___ ___:___ ___ |
_________________ |
__ __ __ |
O- |
O+ |
N/A |
||||||
____/____/_____ |
ISBT-128 |
Entire unit Partial unit ______mL |
__ __ __ __ __ |
___/___/_____ |
A- |
A+ |
B- |
N |
|||
___ ___:___ ___ |
Codabar |
__ __ |
|||||||||
____/____/_____ |
___ ___ ___ ___ ___ |
__ __ __ __ __ __ |
_____ : _____ |
B+ |
AB- |
AB+ |
|||||
___ ___:___ ___ |
_________________ |
__ __ __ |
O- |
O+ |
N/A |
Page
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Haass, Kathryn (CDC/OID/NCEZID) (CTR) |
File Modified | 0000-00-00 |
File Created | 2021-01-22 |